scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/J.IT.2008.02.008 |
P698 | PubMed publication ID | 18440864 |
P2093 | author name string | Francesco Pallone | |
Giovanni Monteleone | |||
Thomas T MacDonald | |||
P2860 | cites work | Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 |
P433 | issue | 6 | |
P921 | main subject | interleukins | Q194908 |
P304 | page(s) | 290-294 | |
P577 | publication date | 2008-04-25 | |
P1433 | published in | Trends in Immunology | Q15265730 |
P1476 | title | Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses | |
P478 | volume | 29 |
Q49841249 | A pilot study on the characteristics of circulating T follicular helper cells in liver transplant recipients |
Q36907647 | A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis |
Q42246581 | Analysis of the mucosal immune responses induced by single and trickle infections with the bovine abomasal nematode Ostertagia ostertagi |
Q51052885 | Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease. |
Q45738584 | Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome |
Q35669245 | Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes |
Q39283252 | CREM Alpha Enhances IL-21 Production in T Cells In Vivo and In Vitro |
Q30436283 | Cutting edge: genetic characterization of IFN-producing killer dendritic cells. |
Q37353862 | Detecting shared pathogenesis from the shared genetics of immune-related diseases |
Q37977126 | Direct and indirect regulatory mechanisms in TH17 cell differentiation and functions |
Q46779685 | Donor Th17 cells and IL-21 may contribute to the development of chronic graft-versus-host disease after allogeneic transplantation. |
Q36305622 | Elevated expression of interleukin-21 and its correlation to T-cell subpopulation in patients with ulcerative colitis |
Q34547617 | Exclusion of IL-21 in the pathogenesis of OVA-induced asthma in mice. |
Q46022940 | Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4(+)CD25 (+) T cells. |
Q39001895 | Exploring the IL-21-STAT3 axis as therapeutic target for Sézary syndrome. |
Q26769670 | Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype |
Q37866624 | HIV-specific CD4 T cells and immune control of viral replication |
Q34320455 | Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors |
Q46309160 | IL-15 positively regulates IL-21 production in celiac disease mucosa. |
Q38243870 | IL-21 as a therapeutic target in inflammatory disorders |
Q37484523 | IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation |
Q35840846 | Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands |
Q26823647 | Inflammatory cytokines in systemic lupus erythematosus |
Q54333384 | Interleukin-21 expression and its association with proinflammatory cytokines in untreated chronic periodontitis patients. |
Q41549665 | Interleukin-21 gene polymorphism rs2221903 is associated with disease activity in patients with rheumatoid arthritis |
Q42279852 | Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells |
Q34002864 | Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus |
Q58434904 | Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis |
Q41200516 | Involvement of interleukin-21 in the pathophysiology of aplastic anemia |
Q39590657 | Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses |
Q38125275 | Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease. |
Q95642187 | Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors |
Q35596715 | Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus |
Q37845585 | Progesterone activates multiple innate immune pathways in Chlamydia trachomatis-infected endocervical cells. |
Q37789387 | Psoriasis: from pathogenesis to novel therapeutic approaches |
Q64271648 | Relationships Between Phenotype and Function of Blood CD4+ T-Cells and Ascending Thoracic Aortic Aneurysm: an Experimental Study |
Q46987803 | Role of IL-21 in inflammatory bowel disease |
Q55263188 | Role of interleukin-21 and interleukin-21 receptor polymorphisms in the treatment of HBeAg-positive chronic hepatitis B patients with peginterferon. |
Q37164125 | Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. |
Q37851522 | Targeting interleukin-21 in inflammatory diseases |
Q38810926 | Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers |
Q36520827 | Th17 cell enhances CD8 T-cell cytotoxicity via IL-21 production in emphysema mice |
Q35327827 | Th17 cells and transplant acceptance |
Q21284677 | Th17 cells in autoimmune and infectious diseases |
Q35116966 | The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III |
Q37557971 | The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I |
Q51152901 | The circadian gene Arntl2 on distal mouse chromosome 6 controls thymocyte apoptosis. |
Q41892056 | The expression levels of transcription factors T-bet, GATA-3, RORγt and FOXP3 in peripheral blood lymphocyte (PBL) of patients with liver cancer and their significance |
Search more.